CLVS | Clovis Oncology (NASDAQ:CLVS) Given Average Rating of “Hold” by Analysts

Clovis Oncology (NASDAQ:CLVS) has been assigned an average rating of “Hold” from the eleven research firms that are presently covering the firm, MarketBeat reports.Three investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and two have assigned a buy recommendation to the company.The average twelve-month price […]The Olympia […]